Delivery Order SPE2DB22D2009-SPE2DB25FL9DQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement of this diabetes medication from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5ml), a diabetes medication. This firm fixed price, competitively awarded delivery order was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $2,853.81 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract utilizes firm fixed pricing and is classified as a non-set-aside award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,654.60 by the Defense Logistics Agency on November 14, 2025. The contract calls for delivery of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml units), a diabetes management medication, with an ultimate completion date of November 17, 2025. This delivery order utilizes firm fixed price pricing and was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $27,918.05 and ultimate completion date of August 6, 2025. This non-set-aside contract represents a single delivery order for the diabetes medication, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,809.48 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under firm fixed price terms with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,672.73 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This firm fixed-price, competitively awarded contract was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,611.61 by the Defense Logistics Agency (DLA) on December 15, 2025, with an ultimate completion date of December 16, 2025. The delivery order procures Mounjaro 2.5 mg/0.5 mL pen injections (0.5 mL), a diabetes medication, under firm fixed price terms with no set-aside designation. This award represents a competitive procurement executed through...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FL9DQDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on May 8, 2025, for Mounjaro 15 mg/0.5 ml pen (a diabetes medication), with a contract ceiling value of $1,108.24 and firm fixed pricing. This competitive award, with no set-aside designation, is performed at the contractor's location in Conshohocken, Pennsylvania, and is scheduled for completion by May 9, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains significant federal contracting capacity to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of competitively awarded delivery orders demonstrates its capability to fulfill diverse federal medical procurement requirements ranging from small-value transactions to substantial orders, positioning it as a critical vendor for the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/8/25 |